Literature DB >> 35723794

Quality of Life and Social and Psychological Outcomes in Adulthood Following Allogeneic HSCT in Childhood for Inborn Errors of Immunity.

Bethany Nicholson1, Rupert Goodman1, James Day1,2, Austen Worth3, Ben Carpenter4, Kit Sandford5, Emma C Morris1,2,4, Siobhan O Burns1,2, Deborah Ridout6, Penny Titman3, Mari Campbell7,8.   

Abstract

BACKGROUND: Hematopoietic stem cell transplant (HSCT) is well established as a corrective treatment for many inborn errors of immunity (IEIs) presenting in childhood. Due to improved techniques, more transplants are undertaken and patients are living longer. However, long-term complications can significantly affect future health and quality of life. Previous research has focused on short-term medical outcomes and little is known about health or psychosocial outcomes in adulthood.
OBJECTIVE: This project aimed to ascertain the long-term social and psychological outcomes for adults who underwent HSCT for IEI during childhood.
METHODS: Adult patients, who had all undergone HSCT for IEI during childhood at two specialist immunology services at least 5 years previously, were invited to participate in the study. Questionnaires and practical tasks assessed their current functioning and circumstances. Information was also gathered from medical notes. Data was compared with population norms and a control group of participant-nominated siblings or friends.
RESULTS: Eighty-three patients and 46 matched controls participated in the study. Patients reported significantly better physical health-related quality of life than the general population norm, but significantly worse than matched controls. Patient's self-reported physical health status and the perceived impact of their physical health on everyday life were worse than matched controls and patients reported higher levels of anxiety and lower mood than the general population. For those where their IEI diagnosis was not associated with a learning disability, cognitive function was generally within the normal range.
CONCLUSIONS: Patients who have had a HSCT in childhood report mixed psychosocial outcomes in adulthood. More research is needed to establish screening protocols and targeted interventions to maximize holistic outcomes. CLINICAL IMPLICATIONS: Screening for holistic needs and common mental health difficulties should be part of routine follow-up. Information should be provided to patients and families in order to support decision-making regarding progression to transplant and the early identification of any difficulties.
© 2022. The Author(s).

Entities:  

Keywords:  Very long-term outcome; allogeneic HSCT for IEI; mental health; psychosocial outcome; quality of life

Year:  2022        PMID: 35723794     DOI: 10.1007/s10875-022-01286-6

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  31 in total

1.  Long-term survival and late deaths after hematopoietic cell transplantation for primary immunodeficiency diseases and inborn errors of metabolism.

Authors:  Mary Eapen; Kwang Woo Ahn; Paul J Orchard; Morton J Cowan; Stella M Davies; Anders Fasth; Anna Hassebroek; Mouhab Ayas; Carmem Bonfim; Tracey A O'Brien; Thomas G Gross; Mitchell Horwitz; Edwin Horwitz; Neena Kapoor; Joanne Kurtzberg; Navneet Majhail; Olle Ringden; Paul Szabolcs; Paul Veys; K Scott Baker
Journal:  Biol Blood Marrow Transplant       Date:  2012-03-16       Impact factor: 5.742

2.  Patients with adenosine deaminase deficiency surviving after hematopoietic stem cell transplantation are at high risk of CNS complications.

Authors:  Manfred Hönig; Michael H Albert; Ansgar Schulz; Monika Sparber-Sauer; Catharina Schütz; Bernd Belohradsky; Tayfun Güngör; Markus T Rojewski; Harald Bode; Ulrich Pannicke; Dominique Lippold; Klaus Schwarz; Klaus-Michael Debatin; Michael S Hershfield; Wilhelm Friedrich
Journal:  Blood       Date:  2006-12-21       Impact factor: 22.113

3.  SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery.

Authors:  Elie Haddad; Brent R Logan; Linda M Griffith; Rebecca H Buckley; Roberta E Parrott; Susan E Prockop; Trudy N Small; Jessica Chaisson; Christopher C Dvorak; Megan Murnane; Neena Kapoor; Hisham Abdel-Azim; Imelda C Hanson; Caridad Martinez; Jack J H Bleesing; Sharat Chandra; Angela R Smith; Matthew E Cavanaugh; Soma Jyonouchi; Kathleen E Sullivan; Lauri Burroughs; Suzanne Skoda-Smith; Ann E Haight; Audrey G Tumlin; Troy C Quigg; Candace Taylor; Blachy J Dávila Saldaña; Michael D Keller; Christine M Seroogy; Kenneth B Desantes; Aleksandra Petrovic; Jennifer W Leiding; David C Shyr; Hélène Decaluwe; Pierre Teira; Alfred P Gillio; Alan P Knutsen; Theodore B Moore; Morris Kletzel; John A Craddock; Victor Aquino; Jeffrey H Davis; Lolie C Yu; Geoffrey D E Cuvelier; Jeffrey J Bednarski; Frederick D Goldman; Elizabeth M Kang; Evan Shereck; Matthew H Porteus; James A Connelly; Thomas A Fleisher; Harry L Malech; William T Shearer; Paul Szabolcs; Monica S Thakar; Mark T Vander Lugt; Jennifer Heimall; Ziyan Yin; Michael A Pulsipher; Sung-Yun Pai; Donald B Kohn; Jennifer M Puck; Morton J Cowan; Richard J O'Reilly; Luigi D Notarangelo
Journal:  Blood       Date:  2018-08-28       Impact factor: 22.113

4.  Long-term outcome of hematopoietic stem cell transplantation for IL2RG/JAK3 SCID: a cohort report.

Authors:  Intan Juliana Abd Hamid; Mary A Slatter; Fiona McKendrick; Mark S Pearce; Andrew R Gennery
Journal:  Blood       Date:  2017-02-16       Impact factor: 22.113

5.  Long-term immune reconstitution and clinical outcome after stem cell transplantation for severe T-cell immunodeficiency.

Authors:  Evelina Mazzolari; Concetta Forino; Sara Guerci; Luisa Imberti; Arnalda Lanfranchi; Fulvio Porta; Luigi D Notarangelo
Journal:  J Allergy Clin Immunol       Date:  2007-09-07       Impact factor: 10.793

6.  Long-term outcomes of nonconditioned patients with severe combined immunodeficiency transplanted with HLA-identical or haploidentical bone marrow depleted of T cells with anti-CD6 mAb.

Authors:  Niraj C Patel; Javier Chinen; Howard M Rosenblatt; Imelda C Hanson; Betty S Brown; Mary E Paul; Stuart L Abramson; Jerome Ritz; William T Shearer
Journal:  J Allergy Clin Immunol       Date:  2008-12       Impact factor: 10.793

7.  Comparison of outcomes of hematopoietic stem cell transplantation without chemotherapy conditioning by using matched sibling and unrelated donors for treatment of severe combined immunodeficiency.

Authors:  Christopher C Dvorak; Amel Hassan; Mary A Slatter; Manfred Hönig; Arjan C Lankester; Rebecca H Buckley; Michael A Pulsipher; Jeffrey H Davis; Tayfun Güngör; Melissa Gabriel; Jacob H Bleesing; Nancy Bunin; Petr Sedlacek; James A Connelly; David F Crawford; Luigi D Notarangelo; Sung-Yun Pai; Jake Hassid; Paul Veys; Andrew R Gennery; Morton J Cowan
Journal:  J Allergy Clin Immunol       Date:  2014-08-07       Impact factor: 10.793

8.  SCID patients with ARTEMIS vs RAG deficiencies following HCT: increased risk of late toxicity in ARTEMIS-deficient SCID.

Authors:  Catharina Schuetz; Benedicte Neven; Christopher C Dvorak; Sandrine Leroy; Markus J Ege; Ulrich Pannicke; Klaus Schwarz; Ansgar S Schulz; Manfred Hoenig; Monika Sparber-Sauer; Susanne A Gatz; Christian Denzer; Stephane Blanche; Despina Moshous; Capucine Picard; Biljana N Horn; Jean-Pierre de Villartay; Marina Cavazzana; Klaus-Michael Debatin; Wilhelm Friedrich; Alain Fischer; Morton J Cowan
Journal:  Blood       Date:  2013-10-21       Impact factor: 22.113

Review 9.  Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985-2000.

Authors:  Reinhard A Seger; Tayfun Gungor; Bernd H Belohradsky; Stephane Blanche; Pierre Bordigoni; Paolo Di Bartolomeo; Terence Flood; Paul Landais; Susanna Müller; Hulya Ozsahin; Justen H Passwell; Fulvio Porta; Shimon Slavin; Nico Wulffraat; Felix Zintl; Arnon Nagler; Andrew Cant; Alain Fischer
Journal:  Blood       Date:  2002-08-08       Impact factor: 22.113

10.  Transplantation outcomes for severe combined immunodeficiency, 2000-2009.

Authors:  Sung-Yun Pai; Brent R Logan; Linda M Griffith; Rebecca H Buckley; Roberta E Parrott; Christopher C Dvorak; Neena Kapoor; Imelda C Hanson; Alexandra H Filipovich; Soma Jyonouchi; Kathleen E Sullivan; Trudy N Small; Lauri Burroughs; Suzanne Skoda-Smith; Ann E Haight; Audrey Grizzle; Michael A Pulsipher; Ka Wah Chan; Ramsay L Fuleihan; Elie Haddad; Brett Loechelt; Victor M Aquino; Alfred Gillio; Jeffrey Davis; Alan Knutsen; Angela R Smith; Theodore B Moore; Marlis L Schroeder; Frederick D Goldman; James A Connelly; Matthew H Porteus; Qun Xiang; William T Shearer; Thomas A Fleisher; Donald B Kohn; Jennifer M Puck; Luigi D Notarangelo; Morton J Cowan; Richard J O'Reilly
Journal:  N Engl J Med       Date:  2014-07-31       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.